2,4-Dichloro-5-iodo-7-(oxetan-3-yl)-7H-pyrrolo[2,3-d]pyrimidine

Catalog No. :
ACLRUT876
CAS No. :
2056937-95-0
Molecular Formula :
C9H6Cl2IN3O
Molecular Weight :
369.98

IUPAC Name:2,4-dichloro-5-iodo-7-(oxetan-3-yl)-7H-pyrrolo[2,3-d]pyrimidine

2,4-Dichloro-5-iodo-7-(oxetan-3-yl)-7H-pyrrolo[2,3-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$79.00Login to see priceIn stockInquiry
250mg95%$134.00Login to see priceIn stockInquiry
1g95%$358.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,4-Dichloro-5-iodo-7-(oxetan-3-yl)-7H-pyrrolo[2,3-d]pyrimidine
IUPAC Name2,4-dichloro-5-iodo-7-(oxetan-3-yl)-7H-pyrrolo[2,3-d]pyrimidine
MDL No.0
Molecular FormulaC9H6Cl2IN3O
Molecular Weight369.98
SMILESClC1=NC(Cl)=C2C(I)=CN(C3COC3)C2=N1
InChI KeyPJZFPBSDHQTQIK-UHFFFAOYSA-N
Synonym2,4-Dichloro-5-iodo-7-(oxetan-3-yl)-7H-pyrrolo[2,3-d]pyrimidine
CAS No.2056937-95-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACLRUT876 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKBRD053 route compound structure diagram
    ACKBRD05339267-79-3 In Stock
  2. Plus
  3. ACKNVU104 route compound structure diagram
    ACKNVU1041012785-51-1 In Stock
  4. Then
  5. ACLRUT876 route product structure diagram
    ACLRUT8762056937-95-0 In Stock
Inquiry

2. ACLRUT876 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKNVU104 route compound structure diagram
    ACKNVU1041012785-51-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLRUT876 route product structure diagram
    ACLRUT8762056937-95-0 In Stock
Inquiry

Comments (0)